Xeroderma pigmentosum complementation group F

Genetic variation in ERCC1 and XPF genes and breast cancer risk

X. H. Pei, Yang, Z., Lv, X. Q., and Li, H. X., Genetic variation in ERCC1 and XPF genes and breast cancer risk, vol. 13, pp. 2259-2267, 2014.

Breast cancer is one of the most frequently diagnosed cancer in women worldwide, and we conducted a case-control study by genotyping seven potentially functional SNPs, three in ERCC1 and four in XPF, in a Chinese population of 417 breast cancer cases and 417 cancer-free controls. Three SNPs in ERCC1 and four SNPs in XPF were genotyped by using the Taqman Universal PCR Master Mix in the GeneAmp® PCR System 9700 with Dual 384-Well Sample Block Module, and assays were performed on a 384-well plate on the Sequenom MassARRAY platform.

Association of polymorphisms of the xeroderma pigmentosum complementation group F gene with increased glioma risk

W. K. Zhou, Huang, L. Y., Hui, L., Wang, Z. W., Jin, B. Z., Zhao, X. L., Zhang, X. Z., Wang, J. X., Wang, J. C., and Wang, R. Z., Association of polymorphisms of the xeroderma pigmentosum complementation group F gene with increased glioma risk, vol. 13, pp. 3826-3831, 2014.

We aimed to investigate the role of 4 single nucleotide polymorphisms of the xeroderma pigmentosum complementation group F (XPF) gene (rs3136038, rs1799798, rs1800067, and rs2276466) in glioma, and the roles of gene-gene interactions in the risk of developing this type of cancer. We collected samples from 225 glioma cases and 262 controls and genotyped the rs3136038, rs1799798, rs1800067, and rs2276466 polymorphisms using a 384-well plate format with the Sequenom MassARRAY platform.

Subscribe to Xeroderma pigmentosum complementation group F